Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AF0E | ISIN: US24906P1093 | Ticker-Symbol: DY2
Tradegate
13.02.26 | 19:00
10,985 Euro
+0,69 % +0,075
1-Jahres-Chart
DENTSPLY SIRONA INC Chart 1 Jahr
5-Tage-Chart
DENTSPLY SIRONA INC 5-Tage-Chart
RealtimeGeldBriefZeit
10,84010,98019:04
10,86010,96013.02.
GlobeNewswire (Europe)
217 Leser
Artikel bewerten:
(1)

DENTSPLY SIRONA Inc.: Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization

CHARLOTTE, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization, effective January 28.

The appointment supports Dentsply Sirona's continued focus on strengthening commercial execution, deepening customer relationships and accelerating growth across the Americas. Mr. Bezjak is a seasoned commercial executive with more than 20 years of experience leading large-scale, multi-billion-dollar organizations in the medical device industry. He joins Dentsply Sirona from Zimmer Biomet, a global medical technology company, where he most recently served as President of the Americas division. Throughout his career, he has led comprehensive commercial transformations, advanced technology-enabled solutions and delivered consistent revenue and operating income growth.

"Mark's appointment is a critical step in ensuring we have the right leadership in place to execute our growth strategy," said Aldo Denti, EVP, Chief Commercial Officer of Dentsply Sirona. "He brings deep commercial expertise, a strong customer-first mindset and a proven ability to build high-performing teams, modernize go-to-market strategies, and drive disciplined growth. His experience in Orthopedics-a highly demanding, customer-first market where success depends on close clinician engagement, rapid problem-solving, and strong field execution-aligns perfectly with our goal of elevating customer focus and strengthening how we serve the dental community."

Mr. Bezjak said, "I am excited to join Dentsply Sirona at an important moment for the company. I look forward to working closely with Aldo and the broader leadership team to strengthen commercial execution, support our customers and build a foundation for sustained growth across the Americas."

About Mark R. Bezjak

Mr. Bezjak held multiple senior leadership roles at Zimmer Biomet, including President of the Americas, President of North America, and Vice President and General Manager, North America. He has extensive experience in medical device, commercial transformation, financial management and technology-driven growth initiatives. At Zimmer Biomet, Mr. Bezjak led the commercial transition from an implant to a technology company, developed commercial go-to-market strategies for new products, drove pricing strategies and transformed commercial organizations to drive enhanced sales and profitability goals. Before joining Zimmer Biomet in 2008, he worked for Arrow International and Michelin North America. Mr. Bezjak holds a Bachelor of Science in Marketing from Virginia Polytechnic Institute and State University (Virginia Tech) and an MBA from the University of Richmond.

About Dentsply Sirona

Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona's innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona's headquarters is located in Charlotte, North Carolina. The Company's shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

Contact Information

Investors:
Wade Moody
Senior Manager, Investor Relations
InvestorRelations@dentsplysirona.com


© 2026 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.